source name	characteristics[organism]	characteristics[organism part]	characteristics[cell type]	characteristics[ancestry category]	characteristics[age]	characteristics[sex]	characteristics[disease]	characteristics[individual]	characteristics[phenotype]	characteristics[specimen]	characteristics[biological replicate]	material type	assay name	technology type	comment[data file]	comment[file uri]	comment[technical replicate]	comment[fraction identifier]	comment[label]	comment[instrument]	comment[MS2 analyzer type]	comment[depletion]	comment[collision energy]	comment[dissociation method]	comment[cleavage agent details]	comment[modification parameters]	comment[modification parameters]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[number of missed cleavages]	factor value[phenotype]
sample1	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 1	liver neoplasm	neoplastic sample	1	tissue	OEI06439	proteomic profiling by mass spectrometry	OEI06439.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06439.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	hcc
sample2	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 1	normal	reference sample	1	tissue	OEI06441	proteomic profiling by mass spectrometry	OEI06441.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06441.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	control
sample3	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 2	liver neoplasm	neoplastic sample	1	tissue	OEI06443	proteomic profiling by mass spectrometry	OEI06443.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06443.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	hcc
sample4	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 2	normal	reference sample	1	tissue	OEI06445	proteomic profiling by mass spectrometry	OEI06445.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06445.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	control
sample5	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 3	liver neoplasm	neoplastic sample	1	tissue	OEI06447	proteomic profiling by mass spectrometry	OEI06447.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06447.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	hcc
sample6	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 3	normal	reference sample	1	tissue	OEI06449	proteomic profiling by mass spectrometry	OEI06449.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06449.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	control
sample7	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 4	liver neoplasm	neoplastic sample	1	tissue	OEI06453	proteomic profiling by mass spectrometry	OEI06453.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06453.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	hcc
sample8	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 4	normal	reference sample	1	tissue	OEI06455	proteomic profiling by mass spectrometry	OEI06455.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06455.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	control
sample9	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 5	liver neoplasm	neoplastic sample	1	tissue	OEI06459	proteomic profiling by mass spectrometry	OEI06459.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06459.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	hcc
sample10	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 5	normal	reference sample	1	tissue	OEI06461	proteomic profiling by mass spectrometry	OEI06461.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06461.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	control
sample11	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 6	liver neoplasm	neoplastic sample	1	tissue	OEI06463	proteomic profiling by mass spectrometry	OEI06463.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06463.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	hcc
sample12	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 6	normal	reference sample	1	tissue	OEI06465	proteomic profiling by mass spectrometry	OEI06465.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06465.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	control
sample13	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 7	liver neoplasm	neoplastic sample	1	tissue	OEI06467	proteomic profiling by mass spectrometry	OEI06467.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06467.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	hcc
sample14	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 7	normal	reference sample	1	tissue	OEI06469	proteomic profiling by mass spectrometry	OEI06469.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06469.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	control
sample15	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 8	liver neoplasm	neoplastic sample	1	tissue	OEI06471	proteomic profiling by mass spectrometry	OEI06471.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06471.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	hcc
sample16	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 8	normal	reference sample	1	tissue	OEI06473	proteomic profiling by mass spectrometry	OEI06473.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06473.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	control
sample17	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 9	liver neoplasm	neoplastic sample	1	tissue	OEI06475	proteomic profiling by mass spectrometry	OEI06475.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06475.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	hcc
sample18	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 9	normal	reference sample	1	tissue	OEI06477	proteomic profiling by mass spectrometry	OEI06477.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06477.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	control
sample19	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 10	liver neoplasm	neoplastic sample	1	tissue	OEI06481	proteomic profiling by mass spectrometry	OEI06481.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06481.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	hcc
sample20	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 10	normal	reference sample	1	tissue	OEI06483	proteomic profiling by mass spectrometry	OEI06483.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06483.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	control
sample21	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 11	liver neoplasm	neoplastic sample	1	tissue	OEI06485	proteomic profiling by mass spectrometry	OEI06485.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06485.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	hcc
sample22	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 11	normal	reference sample	1	tissue	OEI06487	proteomic profiling by mass spectrometry	OEI06487.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06487.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	control
sample23	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 12	liver neoplasm	neoplastic sample	1	tissue	OEI06489	proteomic profiling by mass spectrometry	OEI06489.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06489.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	hcc
sample24	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 12	normal	reference sample	1	tissue	OEI06491	proteomic profiling by mass spectrometry	OEI06491.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06491.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	control
sample25	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 13	liver neoplasm	neoplastic sample	1	tissue	OEI06493	proteomic profiling by mass spectrometry	OEI06493.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06493.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	hcc
sample26	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 13	normal	reference sample	1	tissue	OEI06495	proteomic profiling by mass spectrometry	OEI06495.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06495.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	control
sample27	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 14	liver neoplasm	neoplastic sample	1	tissue	OEI06497	proteomic profiling by mass spectrometry	OEI06497.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06497.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	hcc
sample28	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 14	normal	reference sample	1	tissue	OEI06499	proteomic profiling by mass spectrometry	OEI06499.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06499.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	control
sample29	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 15	liver neoplasm	neoplastic sample	1	tissue	OEI06504	proteomic profiling by mass spectrometry	OEI06504.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06504.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	hcc
sample30	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 15	normal	reference sample	1	tissue	OEI06506	proteomic profiling by mass spectrometry	OEI06506.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06506.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	control
sample31	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 16	liver neoplasm	neoplastic sample	1	tissue	OEI06508	proteomic profiling by mass spectrometry	OEI06508.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06508.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	hcc
sample32	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 16	normal	reference sample	1	tissue	OEI06510	proteomic profiling by mass spectrometry	OEI06510.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06510.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	control
sample33	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 17	liver neoplasm	neoplastic sample	1	tissue	OEI06518	proteomic profiling by mass spectrometry	OEI06518.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06518.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	hcc
sample34	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 17	normal	reference sample	1	tissue	OEI06520	proteomic profiling by mass spectrometry	OEI06520.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06520.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	control
sample35	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 18	liver neoplasm	neoplastic sample	1	tissue	OEI06522	proteomic profiling by mass spectrometry	OEI06522.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06522.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	hcc
sample36	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 18	normal	reference sample	1	tissue	OEI06526	proteomic profiling by mass spectrometry	OEI06526.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06526.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	control
sample37	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 19	liver neoplasm	neoplastic sample	1	tissue	OEI06528	proteomic profiling by mass spectrometry	OEI06528.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06528.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	hcc
sample38	homo sapiens	liver	not applicable	not available	not available	not available	hepatocellular carcinoma	patient 19	normal	reference sample	1	tissue	OEI06530	proteomic profiling by mass spectrometry	OEI06530.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2016/04/PXD002171/OEI06530.raw	1	1	AC=MS:1002038;NT=label free sample	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=linear ion trap;AC=MS:1000291	no depletion	35% NCE	NT=collision-induced dissociation;AC=MS:1000133	NT=Trypsin;AC=MS:1001251	NT=Oxidation; MT=Variable;AC=Unimod:35; TA=M	NT=Propionamide; MT=Variable;AC=Unimod:24; TA=C	5 ppm	0.4 Da	1	control
